Brink Therapeutics is a venture-backed biotech company specializing in the development of cutting-edge gene therapy tools. We focus on site-specific recombinases, highly efficient enzymes that enable precise DNA modifications - such as inserting, removing, or inverting
— About Eligo — Eligo Bioscience, backed by top-tier investors from Silicon Valley and Europe, is pioneering next-generation microbiome therapeutics. Co-founded by MIT and Rockefeller University scientists, Eligo is headquartered in Paris, France. Our mission is
Join our Translational Pharmacology team, based in Paris, as an intern (for a minimum period of 5 months) and contribute to the development of innovative preclinical models to test the efficacy of Eligobiotics®. You will be